Mitochon Pharmaceuticals

Mitochon Pharmaceuticals Overview

Founded 2015
Founded
Status Private
Employees 5
Employees
Latest Deal Type Early Stage VC
Latest Deal Amount $1.5M
Latest Deal Amount
Investors 3

Mitochon Pharmaceuticals General Information

Description

Operator of a clinical-stage biotech company, with an open IND and in Phase I testing. The company is focused on developing disease-modifying drugs that target the mitochondria and attenuate neurodegeneration, with a focus on Huntington's Disease, ALS, Progressive Supranuclear Palsy, MS and Parkinson's. Its programs to date have been shown to protect cells by modulating the mitochondria to reduce oxidative stress, Improve Calcium handling, and promote mitochondrial biogenesis. Together these effects create stronger, healthier and more resilient cells whose natural compensatory mechanisms resist disease processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 970 Cross Lane
  • Blue Bell, PA 19422
  • United States
+1 (215) 000-0000

Mitochon Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitochon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 30-Nov-2019 $1.5M 00.000 Completed Clinical Trials - Phase 1
4. Angel (individual) 21-Dec-2017 00000 00.000 Completed Generating Revenue
3. Grant 03-Oct-2017 000 00.000 Completed Generating Revenue
2. Early Stage VC 17-May-2016 $1.6M $2.35M Completed Generating Revenue
1. Early Stage VC 31-Mar-2015 $750K $750K Completed Generating Revenue

Mitochon Pharmaceuticals Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Epirium Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000000000 000 Venture Capital-Backed Yerushalayim, Israel 0000 00000000000 0000
0000000000 Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000

Mitochon Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Robert Alonso Co-Founder, President & Chief Executive Officer
John Geisler Ph.D Co-Founder & Chief Scientific Officer
Marcus Keep MD Acting Chief Medical Officer

3 Former Executives

Mitochon Pharmaceuticals Board Members (1)

Name Representing Role Since
Anthony Jannetta Mitochon Pharmaceuticals Board Member 000 0000

Mitochon Pharmaceuticals Investors (3)

To view Mitochon Pharmaceuticals‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Michael J. Fox Foundation Limited Partner Minority 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
YT Angels Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial